+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 65Years +
All Genders
ID07866768

Safety and Usability Study of ATTN201 Ultrasound Device for Amyloid-Positive Mild Cognitive Impairment in Older Adults

Led by University of California, San Francisco · Updated on 2026-10-14

28

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and usability of a wearable ultrasound device called ATTN201 in adults aged 65 and older who have mild cognitive impairment MCI and amyloid buildup in the brain, an early sign of Alzheimers disease. This pilot study compares focused low-intensity ultrasound targeting a deep brain area involved in sleep regulation to unfocused ultrasound, which acts as a control. The study investigates whether focused ultrasound can enhance deep-sleep brain waves that may help clear brain waste, including amyloid. Participants will be randomly assigned to receive either focused or unfocused ultrasound via the head-worn ATTN201 device during 10 nap sessions over two weeks, conducted at home or at the study site. Before treatment, individualized targeting is done using MRI scans. The focused ultrasound is designed to stimulate the centromedian nucleus of the thalamus, while the unfocused ultrasound mimics the sensation without targeting the brain. The study includes baseline and post-treatment assessments, with an optional follow-up visit three months later. During the study, participants will undergo memory and cognitive tests, blood draws, neurological exams, and MRI scans. Sleep will be recorded at home using diaries, a watch-like sensor, and a brain wave-monitoring headband over at least five days. Continuous monitoring during treatment includes EEG and symptom assessments. Researchers will measure safety outcomes, adherence, changes in sleep patterns, cognitive function, and Alzheimers disease biomarkers. The total involvement spans about five months including follow-up.

CONDITIONS

Brief Title

CMN LIFU for Enhanced Glymphatic Clearance in Amyloid-Positive MCI

Research Team

A

Andrew D Krystal, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here